Clinical Trial Update: Intravenous Levetiracetam as First-line Anticonvulsive Treatment in Patients With Non-convulsive Status Epilepticus [Phase 2]

View source ↗

Summary

The Phase 2 trial NCT00603135 evaluating intravenous levetiracetam as first-line anticonvulsive treatment for non-convulsive status epilepticus has been withdra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-convulsive Status Epilepticus

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Status Epilepticus, Non-Convulsive | Phase 2 | Status: WITHDRAWN